Answers are grounded in this paper and cite their sources.
AS patients appear to be at higher risk of MI, which could be due to low HDL cholesterol levels or to systemic inflammation. Management of cardiovascular risk factors and control of systemic inflammation should be taken into account in AS.
No takes yet. Share an insight, caveat, or question.
Mathieu et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: